ONCOTHERAPY SCIENCE, INC.

Andere talen OncoTherapy Science, Inc.

Aandelen

4564

JP3202150003

Vertraagde tijd Japan Exchange Andere beurzen 06:04:17 24-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24 ^JPY	+9,09%		+60,00%	+4,35%

29/04	Polen's Tusk belt openbaar aanklager over mogelijk Orlen-schandaal	RE
2023	OncoTherapy Science, Inc. meldt winstresultaten voor het volledige jaar eindigend op 31 maart 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	14/05
Poland's Tusk calls prosecutor over potential Orlen scandal	29/04
OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	22/04
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	05/04
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.	05/12
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index	18-09-23
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12-05-23
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding	10-04-23
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding	24-03-23
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer	13-09-22
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	28-04-21
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	12-04-21
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine	01-10-20
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.	15-01-19
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.	26-12-18
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	14-07-17
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index	29-06-15
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	31-07-13
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	02-04-12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.

PROFITEER NU